AzTrials
AzTrials

EpilepsyNCT07663240

Epilepsy Emergency Department High Utilizer Program

An observational study of Epilepsy and Uncontrolled Seizures, run by Morehouse School of Medicine at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

We believe that there are many reasons that people with epilepsy get their health care through the emergency department (ED) instead of through primary care or neurology. Our goal is to create program that will address these reasons. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Epilepsy, Uncontrolled Seizures
What is being tested?
CHW-Led Transition-of-Care Intervention
How many people
15 participants
Where
1 siteUnited States
Study dates
1 May 2026to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population includes adult women with a confirmed diagnosis of epilepsy who are high utilizers of emergency department services at Grady Health System. Participants are enrolled through the Transition of Care (TOC) ED High Utilizer Program and have a history of frequent seizure-related ED visits. The study focuses on Black and Hispanic women residing in the Atlanta metropolitan area.

Who may be able to join

  • Adult women aged 18 years or older
  • Confirmed diagnosis of epilepsy documented in the electronic health record (EHR)
  • Enrolled in the Grady Health System Transition of Care (TOC) ED High Utilizer Program
  • History of three or more seizure-related emergency department visits within the past 12 months
  • Self-identify as Black or Hispanic
  • Reside in the Atlanta metropolitan area with intent to remain for at least 12 months
  • Have access to a working phone for follow-up communication

Who cannot join

  • No confirmed epilepsy diagnosis (e.g., non-epileptic seizures)
  • Younger than 18 years of age
  • Not identified as a high ED utilizer for seizure-related care
  • Unable to provide informed consent due to cognitive impairment or psychiatric instability
  • Regularly taking anti-epileptic medications with established adherence
  • Scheduled neurology follow-up within 14 days of discharge or consistent primary care follow-up
Show all 9Show fewer
  • Complex medical conditions that would limit participation in outpatient follow-up
  • Non-English speaking
  • Pregnant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Morehouse School of Medicine

    Atlanta, Georgia, 30310

Other trials in United States

About this study

We believe that there are many reasons that people with epilepsy get their health care through the emergency department (ED) instead of through primary care or neurology. Our goal is to create program that will address these reasons. The creation of this program will be informed by use of the Grady electronic health records (EHR). We will use the EHR to describe people with epilepsy coming the Grady ED at a high frequency. We create a profile of these patients by examining their demographics and social determinants of health information in their EHR (Aim 1). We will then use that information to create a culturally and medically appropriate program for people with epilepsy (Aim 2). Next, we will test the new program, the Epilepsy Emergency Department High Utilizer Program (Aim 3). We believe this program may improve three things. It will first improve access to care by epilepsy and mental health doctors, and reduce ED visits. It may also help people to manage their triggers, track seizures, and take their medicines on time. And last, we believe it may improve seizure frequency and quality of life for people that are underserved in health care. With the lessons learned from the new program, we will explore ways to sustain the program at Grady and expand it to other health care facilities (Aim 4).

Being tested
CHW-Led Transition-of-Care Intervention
Keywords
Epilepsy, Uncontrolled seizured, Frequent ED use, High utilizers, Community Health Worker, Care coordination, African American / Black, Underserved populations, Social determinants of health, Multidisciplinary care, Integrated care, Transitions of Care Program
Medical subject headings
Epilepsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CHW-Led Transition-of-Care InterventionBehavioural

    Participants receive a community health worker (CHW)-led transition-of-care intervention for adults with epilepsy who frequently use emergency department services. Over 9-12 months, the CHW provides home visits and phone follow-up to support seizure self-management, medication adherence, and care coordination.

    The CHW assists with appointment scheduling, connects participants to healthcare and community resources, and addresses social needs such as transportation and access to care. The goal is to improve continuity of care and reduce emergency department utilization.

Study groups in NCT07663240
Study groupRoleWhat they receive
CHW-Led Transition-of-Care InterventionThis study evaluates a community health worker (CHW)-led transition-of-care intervention for adults with epilepsy who are high utilizers of emergency department services. Participants are enrolled following identification through the Grady Health System Transition of Care (TOC) ED High Utilizer Program. Participants receive ongoing support from a trained CHW over a 9-12 month period. The intervention includes regular home visits and phone follow-up to support epilepsy self-management, including education on seizure recognition, medication adherence, identification of seizure triggers, and reinforcement of treatment plans. The CHW provides care coordination by assisting with appointment scheduling, facilitating communication with healthcare providers, and supporting linkage to neurology, primary care, behavioral health, and community-based services. The intervention also addresses social determinants of health, including transportation, housing, and access to resources that may impac
Receives: Behavioral: CHW-Led Transition-of-Care Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emergency Department Utilization

    Reduced emergency department visits

    Measured: Baseline to 9-12 months post-enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2026
  2. Study start1 May 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07663240
Sponsor's protocol ID
12345
Other IDs
FY2025-56
Status last verified
May 2026
First submitted
17 Jun 2026
Last updated
23 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data will include demographic characteristics, clinical variables (e.g., seizure frequency, emergency department utilization, medication adherence), and participant-reported outcomes related to epilepsy self-management, quality of life, and behavioral health measures collected during the study period.

Questions about this trial

What is this clinical trial studying?

An observational study of Epilepsy and Uncontrolled Seizures, run by Morehouse School of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 23 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emergency Department Utilization (time frame: Baseline to 9-12 months post-enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in